Skip to content

Drug interactions

Lurbinectedin + Mifepristone

Severity: Major

Lurbinectedin and Mifepristone: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Mifepristone inhibits CYP3A4, the main route of lurbinectedin metabolism, so lurbinectedin exposure may rise. This raises the risk of myelosuppression and hepatotoxicity.

What this interaction means in plain words

Lurbinectedin and Mifepristone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Lurbinectedin belongs to Oncology; Mifepristone belongs to Endocrine.

Evidence level: Moderate

Why it happens

Inhibition of CYP3A4-mediated metabolism of lurbinectedin by mifepristone.

What to do

Avoid the combination. If unavoidable, reduce the lurbinectedin dose by 50% and monitor blood counts and liver tests.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lurbinectedin and Mifepristone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lurbinectedin with Mifepristone?

MediHelp rates the interaction as major. Lurbinectedin and Mifepristone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Mifepristone inhibits CYP3A4, the main route of lurbinectedin metabolism, so lurbinectedin exposure may rise. This raises the risk of myelosuppression and hepatotoxicity.

How serious is the interaction between Lurbinectedin and Mifepristone?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination. If unavoidable, reduce the lurbinectedin dose by 50% and monitor blood counts and liver tests.

What other medicines interact with Mifepristone?

MediHelp also lists interactions of Mifepristone with, for example, Apixaban, Argatroban, Cisapride. The full list is on the Mifepristone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in